The biology of nitrogen oxides in the airways

American Journal of Respiratory and Critical Care Medicine

Volumn 149, Issue 2 I, 1994, Pages 538-551

  Gaston, Benjamin ^b   Drazen, Jeffrey M ^b   Loscalzo, Joseph ^b   Stamler, Jonathan S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGEN DIOXIDE; NITROGEN OXIDE;

AIR POLLUTANT; ARTICLE; CHEMICAL REACTION KINETICS; LUNG DISEASE; LUNG HEMODYNAMICS; LUNG TOXICITY; OXIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TOXIN ANALYSIS;

EID: 0028053211     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.149.2.7508323     Document Type: Article

References (205)

1. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-6.
2. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84:9265-9.
3. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-6.
4. Palmer RMJ, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endotheliumdependent relaxation. Biochem Biophys Res Commun 1988; 153: 1251-6.
5. Sakuma I, Stuehr DJ, Gross SS, Nathan C, Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85:8664-7.
6. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox activated forms. Science 1992; 258:1898-1902.
7. Osier W. The principles and practice of medicine. 1st ed. New York: Appleton, 1892.
8. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338:1173-4.
9. Frostell C, Fratacci M-D, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83:2038-47.
10. Lewandowski K, Slama K, Falke KJ. Approaches to improve survival in severe ARDS. In: Vincent JL, ed. Yearbook of intensive care and emergency medicine. 1992. Berlin: Springer Verlag, 1992; 372-83.
11. Roberts J, Polaner D, Lang P, Zapol W. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:818-9.
12. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405.
13. Goretski J, Hollocher T. Trapping of nitric oxide produced during denitrification by extracellular hemoglobin. J Biol Chem 1988; 263:2316-23.
14. Mirvish S. Formation of N-nitroso compounds: chemistry, kinetics and in vivo occurrence. Toxicol Appl Pharmacol 1975; 31:325-51.
15. Ridd J Diffusion control and pre-association in nitrosation, nitration and halogenation. Adv Phys Organ Chem 1978; 16:1-49.
16. Gillespie R, Humphreys D, Baird NC, Robinson EA. Chemistry. Boston: Allyln and Bacon, 1989; 626-40.
17. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87:1620-4.
18. Radi R, Cosgrove TP, Beckman JS, Freeman BA. Peroxynitrite-induced luminol chemiluminescence. Biochem J 1993; 290:51-7.
19. Marietta MA, Tayeh MA, HevelJM. Unraveling the biological significance of nitric oxide. Biofactors. 1990; 2:219-25.
20. Bunton CA, Llewellyn DR, Stedman G. Recent aspect of the inorganic chemistry of nitrogen. Special publication no. 10. London: The Chemical Society, 1957; 113-20.
21. Marietta MA. Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents. Chem Res Toxicol 1988; 1:249-57.
22. Gaston B, Drazen JM, Lilly C, Sugarbaker DA, Loscalzo J, Stamler JS. Bioactive oxides of nitrogen in the lung: immunity and the neural axis. In: Moncada S, Nistico G, Higgs A, eds. Nitric oxide in brain and Immunity. 1993; Portland Press (In Press).
23. Lopez-Vidriero MT, Das I, Reid LM. Airway secretion: source, biochemical and rheological properties. In: Brain JD, Proctor DF, Reid LM, eds. Respiratory defense mechanisms (Part I). New York: Marcel Dekker, 1977; 289-356.
24. McCleverty JA. Reactions of nitric oxide coordinated to transition metals. Chem Rev 1979; 79:53-76.
25. 2 reaction. Chem Res Toxicol 1993; 6:23-7.
26. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res 1990; 66:1561-75.
27. Stamler JS, Jaraki O, Osborne J, Simon D, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992; 89:7674-7.
28. Foubert L, Fleming B, Latimer R, Jonas M, Oduro A, Borland C, Higenbottam T. Safety guidelines for the use of nitric oxide. Lancet 1992; 339:1615-6.
29. National Research Council: Subcommittee on Nitrogen Oxides. Medical and biological effects of environmental pollutants: nitrogen oxides. Washington DC: National Academy of Sciences, 1977; 6-11.
30. Blough NV, Zafiriou OC. Reaction of superoxide with nitric oxide to form peroxynitrite in alkaline aqueous solution. Inorganic Chem 1985; 24:3502-4.
31. 2-.: Implications for the action of endothelium-derived relaxing factor (EDRF). Free Radic Res Commun 1990; 10:221-6.
32. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynttrile-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288:481-7.
33. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991; 266:4244-50.
34. Wang Q, Jacobs J, DeLeo J, Kruszyna H, Kruszyna R, Smith R, Wilcox D. Nitric oxide hemoglobin in mice and rats in endotoxic shock. Life Sci 1991; 49:55-60.
35. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65:1-21.
36. Wong SK, Garbers DL. Receptors for guanylyl cyclases. J Clin Invest 1992; 90:299-305
37. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6:3051-64.
38. Albina JE, Mills CD, Henry WL, Caldwell MD. Regulation of macrophage physiology by L-arginine: role of the oxidative L-arginine deiminase pathway. J Immunol 1989; 143:3641-6.
39. Hibbs JB, Vavrin Z, Trainor RR. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolism inhibition in target cells. J Immunol 1987; 138:550-65.
40. Hibbs JB, Trainor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157:87-94.
41. Henry Y, Ducrocq C, Drapier J-C, Servent D, Pellat C, Guissani A. Nitric oxide, a biological effector: electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whole cells. Eur Biophys J 1991; 20:1-15.
42. Kanner J, Harel S, Granit R. Nitric oxide as an antioxidant. Arch Biochem Biophys 1991; 289:130-6.
43. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992; 89:444-8
44. 2 and endothelium-dependent cerebral arteriolar dilation. Hypertension 1990; 16:162-9.
45. Myers PR, Minor RL, Guerra R, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 1990; 345:161-3.
46. Stamler JS, Simon DI, Jaraki O, Osborne JA, Francis S, Mullins M, Singel D, Loscalzo J. S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc Natl Acad Sci USA 1992; 89:8087-91.
47. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS, Keefer LK. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991; 254:1001-3.
48. Nguyen T, Bronson D, Crespi CL, Penman BW, Wishok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992; 89:3030-4.
49. Stuehr D, Kwon NS, Nathan C, Griffith O, Feldman P, Wiseman J. N-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem 1991; 266:6259-63.
50. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351:714-8.
51. Förstermann U, Schmidt HHHW, Pollock JS, Sheng H, Mitchell JA, Warner TD, Nakane M, Murad F. Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochem Pharmacol 1991; 42:1849-57.
52. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM. Generation of superoxide by brain nitric oxide synthase. J Biol Chem 1992; 24173-6.
53. 2+/calmodulin-dependent nitric oxide synthase from porcine cerebellum: cofactor role of tetrahydrobiopterin. FEBS Lett 1990; 277:215-9.
54. Hibbs JB, Vavrin Z, Taintor RR. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 1987; 138:550-65.
55. Jorens PG, Van Overveld FJ, Bult H, Vermeire PA, Herman AG. L-arginine-dependent production of nitrogen oxides by rat pulmonary macrophages. Eur J Pharmacol 1991; 200:205-9.
56. Rimele TJ, Sturm RJ, Adams LM, Henry DE, Heaslip RJ, Weichman BM, Grimes D. Interaction of neutrophils with smooth muscle: identification of a neutrophil-derived relaxing factor. J Pharmacol Exp Ther 1988; 245:102-11.
57. Bissonnette EY, Hogaboam CM, Wallace JL, Befus AD. Potentiation of tumor necrosis factor-α-mediated cytotoxicity of mast cells by their production of nitric oxide. J Immunol 1991; 147:3060-5.
58. Bull H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maerke YM, Herman AG. Nitric oxide as an inhibitory non-adrenergic noncholinergic neurotransmitter. Nature 1990; 345:346-346.
59. Belvisi MG, Stretton D, Barnes PJ. Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea-pig airways. Eur J Pharmacol 1991; 198:219-21.
60. Jorens PG, VanOverveld FJ, Bult H, Vermeire PA, Herman AG. Synergism between interleukin-1 beta and interferon-gamma, an inducer of nitric oxide synthase, in rat lung fibroblasts. Eur J Pharmacol 1992; 224:7-12.
61. Busse R, Mülsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 1990; 275:87-90.
62. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61:866-79.
63. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt Y, Large SR, Wells FC, Wallwork J. Impairment of endotheliumdependent pulmonary-artery relaxation in chronic obstructive pulmonary disease. N Engl J Med 1991; 324:1539-47.
64. Chee C, Gaston B, Gerard C, Loscalzo J, Kobzik L, Drazen JM, Stamler J. Nitric oxide is produced by a human epithelial cell line (abstract). Am Rev Respir Dis 1993; 147:A433.
65. Kobzik L, Bredt D, Lowenstein C, Snyder SH, Drazen JM, Sugarbaker D, Stamler JS. Nitric oxide synthase in human and rat lung. Am J Respir Cell Mol Biol 1993; 9:371-7.
66. Schmidt HHHW, Gagne GD, Nakane M, Pollock JS, Miller MF, Murad F. Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J Histochem Cytochem 1992; 40:1439-56.
67. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulinrequiring enzyme. Proc Natl Acad Sci USA 1990; 87:682-5.
68. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive isoform. Proc Natl Acad Sci USA 1992; 89:6348-52.
69. Knowles RG, Merrett M, Salter M, Moncada S. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem J 1990; 270:833-6.
70. Knowles RG, Salter M, Brooks SL, Moncada S. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun 1990; 172:1042-8.
71. Förstermann U, Pollock JS, Schmidt HHHW, Heller M, Murad F. Calmodulin-dependent endothelium derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991; 88:1788-92.
72. Förstermann U, Pollock JS, Schmidt HHHW, Mitchell JA, Kohlhaas KL, Heller M, Murad F. Characterization and purification of particulate EDRF synthase from bovine aortic endothelial cells (abstract). FASEB J 1991; 5:A1728.
73. Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 1992. 267:6370-4.
74. Granger DL, Hibbs JB Jr, Perfect JR, Durack DT Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest 1987;81:1129-36.
75. Green SJ, Nacy CA, Meltzer MS. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J Leukoc Biol 1991; 50:93-103.
76. Wright CD, Mulsch A, Busse R, Osswald H. Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun 1989; 160: 813-9.
77. Yui Y, Hattori R, Kosuga K, Eizawa H, Hiki K, Ohkawa S, Ohnisha K, Terao S, Kawai C. Calmodulin-independent nitric oxide synthase from rat polymorphonuclear neutrophils. J Biol Chem 1991; 266:3369-71.
78. Geller DA, Lowensteine CJ, Shapiro RA, Nussler AK, DiSilvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar TR. Molecular cloning and expression of inducible nitric oxide synthase in human hepatocytes. Proc Natl Acad Sci USA 1993; 90:3491-5.
79. Lambert LE, Whitten JP, Baron BM, Cheng HC, Doherty NS, McDonald IA. Nitric oxide synthesis in the CNS, endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues. Life Sci 1991; 48:69-75.
80. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR Jr, Williamson JR, McDaniel ML. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1992; 41:552-6.
81. Ward PA, Mulligan MS. Anti-inflammatory effects of L-arginine analogues. In: Moncada S, Nistico G, Higgs A, eds. Nitric oxide, brain and immunity 1992; (In Press).
82. Fukuto JM, Wallace GC, Hszieh R, Chaudhuri G. The chemical oxidation of N-hydroxyguanidine compounds: release of nitric oxide, nitroxyl and possible relationship to the mechanism of biological nitric oxide generation. Biochem Pharmacol 1992; 43:607-13.
83. Fukuto JM, Chiang K, Hszieh R, Wong P, Chaudhuri G. The pharmacological activity of nitroxyl (HNO): a potent vasodilator with activity similar to nitric oxide (NO) and/or endothelium-derived relaxing factor (EDRF). J Pharmacol Exp Ther 1992; 236:546-51.
84. White KA, Marietta MA, Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 1992; 28:6627-31.
85. Jansen A, Drazen J, Osborne JA, Brown R, Loscalzo J, Stamler JS. The relaxant properties in guinea pig airways of S-nitrosothiols. J Pharmacol Exp Ther 1992; 261:154-9.
86. Malinski T, Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 1992; 358:676-8.
87. Steinhorn RH, Morin FC, Gugino SF, Giese EC, Russell JA. Nitric oxide (NO) is more effective when delivered from the endothelial side of rabbit pulmonary artery (abstract). Am Rev Respir Dis 1993; 147:A225.
88. Kowaluk EA, Fung H-L. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J Pharmacol Exp Ther 1990; 255:1256-64.
89. Lipton SA, Choi YB, Sizheng ZL, Loscalzo J, Singel D, Stamler JS. A redox based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364:626-32.
90. Morris SL, Walsh RC, Hansen JN. Identification and characterization of some bacterial membrane sulfhydryl groups which are targets of bacteriostatic and antibiotic action. J Biol Chem 1984; 259:13590-4.
91. G-methyl-arginine. Biochem Biophys Res Commun 1990; 170:96-103.
92. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218:739-49.
93. Henry PJ, Drummer OH, Horowitz JD. S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators. Br J Pharmacol 1989; 98:757-66.
94. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181:852-7.
95. Gaston B, Drazen J, Chee CBE, Wohl MEB, Stamler JS. Expired nitric oxide (NO·) concentrations are elevated in patients with reactive airways disease. Endothelium 1993; 1:87.
96. Gaston B, Fackler JC, Drazen JM, Singel DJ, Reilly J, Mullin M, Loscalzo J, Stamler JS. Nitrogen oxides in normal and abnormal tracheal secretions (abstract). Am Rev Respir Dis 1993; 147:A455.
97. Gaston B, Drazen JM, Reilly J, Sugarbaker DJ, Mullins M, Ramdev P, Jaraki O, Singel D, Loscalzo J, Stamler JS. Endogenous nitrogen oxides and bronchodilators s-nitrosothiols in human airways. Proc Natl Acad Sci USA 1993; 90:10957-61.
98. Cremona G, Takao M, Higenbottam T. Differences in exhaled nitric oxide (NO) between intact pigs and isolated lungs perfused with krebsdextran-albumin (abstract). Am Rev Respir Dis 1993; 147:A226.
99. Springall DR, Hamid OA, Buttery LKD, Chanea P, Howarth P, Bousquet J, Holgate ST, Polak JM. Nitric oxide synthase induction in airways of asthmatic subjects (abstract). Am Rev Respir Dis 1993; 147:A515.
100. Ignarro LJ, Edwards JC, Gruetter DY, Barry BK, Gruetter CA. Possible involvement of S-nitrosothiols in the activation of guanylate cyclase nitroso compounds. FEBS Lett 1980; 110:275-8.
101. Goldstein JA. Nitroglycerin therapy of asthma. Chest 1984; 85:449.
102. Miller WC, Shultz TF. Failure of nitroglycerin as a bronchodilator. Am Rev Respir Dis 1979; 120:471.
103. Okayama M, Sasaki H, Takishima T. Bronchodilator effect of sublingual isosorbide dinitrate in asthma. Eur J Pharmacol 1984; 26:151-5.
104. Gregori P. Zur broncholytischen Wirksamkeit von Nitroglyzerin. Z Gesamte Inn Med 1980; 35:107-12.
105. Tullett WM, Patel KR. Isosorbide dinitrate and isoxsuprine in exercise induced asthma. Br Med J 1983; 280:1934-5.
106. Csete M, Abraham W, Wanner A. Vasomotion influences airflow in peripheral airways. Am Rev Respir Dis 1990; 141:1409-13.
107. Byrick R, Hobbs E, Martineau R, Noble W. Nitroglycerin relaxes large airways. Anesth Analg 1983; 62:421-5.
108. Csete M, Chediak A, Abraham W, Wanner A. Airway blood flow modifies allergic airway smooth muscle contraction. Am Rev Respir Dis 1991; 144:59-63.
109. Niehues B, Romer C, Thoma R, Behrenbeck W, Hilger H. Nitroglycerin bei chronisch obstruktiver lungenerkrankung. Dtsch Med Wochenschr 1979; 104:691-6.
110. Radenbach D, Oltmanns D, Hell G. Nitroglycerin wirkt auch broncholystisch. Med Klin 1981; 76:685-8.
111. Gruetter CA, Childers CE, Bosserman MK, Lemke SM, Ball JG, Valentovic MA. Comparison of relaxation induced by glyceryl trinitrate, isosorbide dinitrate, and sodium nitroprusside in bovine airways. Am Rev Respir Dis 1989; 139:1192-7.
112. Aviado DM, Kishimoto T, Kneidinger HJ. Bronchopulmonary effects of pentaerythrityl tetranitrate and isoproterenol. J Pharmacol Exp Ther 1969; 165:274-85.
113. Maruyama M, Satoh K, Taira N. Effects of nicorandil and its congeners on musculature and vasculature of the dog trachea in situ. Arch Int Pharmacodyn 1982; 258:260-6.
114. Kennedy T, Summer WR, Sylvester J, Robertson D. Airway response to sublingual nitroglycerin in acute asthma. JAMA 1981; 246:145-7.
115. Buga GM, Gold ME, Wood KS, Chaudhuri G, Ignarro LJ. Endothelium: derived nitric oxide relaxes nonvascular smooth muscle. Eur J Pharmacol 1989; 161:61-72.
116. Munakata M, Masaki Y, Sakuma I, Ukita H, Otsuka Y, Homma Y, Kawakami Y. Pharmacological differentiation of epithelium-derived relaxing factor from nitric oxide. J Appl Physiol 1990; 69:665-70.
117. Gaston B, Drazen JM, Jansen A, Sugarbaker DA, Loscalzo J, Stamler JS. Relaxation of human airways in vitro by s-nitrosothiols. J Pharm Exp Ther 1993; (In Press).
118. Katsuki S, Murad F. Regulation of adenosine cyclic 3′,5′-monophosphate and guanosine cyclic 3′-5′-monophosphate levels and contractility in bovine tracheal smooth muscle. Mol Pharmacol 1976; 13:330-41
119. Bynoe TC, Stuart-Smith K, Hirshman CA. Porcine bronchial smooth muscle exhibits functional antagonism to relaxation to sodium nitroprusside and SIN-1 (abstract). Am Rev Respir Dis 1992; 145:A399.
120. Dupuy P, Shore S, Drazen J, Frostell C, Hill A, Zapol W. Bronchodilatory action of inhaled nitric oxide in guinea pigs. J Clin Invest 1992; 90:421-8.
121. Shore SA, Romero L. Effect of a nitric oxide synthase inhibitor on bronchoconstriction induced by intravenous histamine (abstract). Am Rev Respir Dis 1993; 147:A445.
122. Nijkamp FP, van der Linde HJ, Folerts G. Nitric oxide synthesis inhibition induces airway hyperresponsiveness: role of the epithelium (abstract). Am Rev Respir Dis 1993; 147:A287.
123. 2-nitrogen in isolated rat lungs. Toxicol Appl Pharmacol 1988; 98:303-12.
124. Cherry PD, Omar HA, Farrell KA, Stuart JS, Wolin MS, Superoxide anion inhibits cGMP-associated bovine pulmonary arterial relaxation. Am J Physiol. 1990; 259:H1056-62.
125. Aviado D, Samaner M, Palecer F, Bellet S. Bronchodilator action of pentaerythrityl tetranitrate in experimental pulmonary embolism. Cardiologia. 1968; 52:340-61.
126. Ferguson MK. Evidence supporting nitric oxide as an endothelium- dependent relaxant factor in lymph vessels (abstract). Am Rev Respir Dis 1992; 145:A207.
127. Liu SF, Crawley DE, Rohde JAL, Evans TW, Barnes PJ. Role of nitric oxide and guanosine 3′,5′-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries. Br J Pharmacol 1992; 107:861-6.
128. Channick RN, Bradley SP, Newhart JW, Johnson FW, Konopka RG, Permpikul C, Moser KM. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction in dogs (abstract). Am Rev Respir Dis 1992; 145:A209.
129. Liu SF, Crawley DE, Evans TW, Barnes PJ. Endogenous nitric oxide modulates adrenergic neural vasoconstriction in guinea-pig pulmonary artery. Br J Pharmacol 1991; 104:565-9.
130. Namiki A, Yukio H, Ishikawa M, Moroi M, Aikawa J, Machii K. Endothelin-1 and Endothelin-3-induced vasorelaxation via common generation of dothelium-derived nitric oxide. Life Sciences 1992; 50:677-82.
131. Stamler JS, Loh E, Roddy MA, Hoffman KE, Creager MA. Nitric oxide regulates pulmonary vascular resistance in normal human subjects. Clin Res 1993; 41;190A.
132. Cremona G, Higenbottam T, Wood AM, Dinh-Xuan AT. Importance of endogenous nitric oxide in the adaptation to increased blood flow in isolated human and sheep lungs (abstract). Am Rev Respir Dis 1992; 145:A206.
133. Cook JP, Stamler JS, Andon N, Davies PF, McKinley G, Loscalzo J. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol 1990; 259:H804-12.
134. Leeman M, Zegers de Beyl V, Gilbert E, Melot C, Naeije R. Endotheliumderived relaxing factor (EDRF) modulates pulmonary hypertension in canine oleic acid lung injury (abstract). Am Rev Respir Dis 1992; 145:A206.
135. Bhattacharya S, Bhattacharya J. Bay K8644 induced segmental release of endothelium derived relaxing factor (EDRF) in pulmonary circulation of rat (abstract). Am Rev Respir Dis 1992; 145:A208.
136. Ku DD, Ann HS. Magnesium deficiency produces endothelium-dependent vasorelaxation in canine coronary arteries. J Pharmacol Exp Ther 1987; 241:961-6.
137. Moinard J, Pillet O, Castaing, Guenard H. Inhaled nitric oxide: effects on pulmonary circulation and gas exchange in man (abstract). Am Rev Respir Dis 1992; 145:A207.
138. Liu SF, Hislop AA, Haworth SG, Barnes PJ. Developmental changes in endothelium-dependent pulmonary vasodilatation in pigs. Br J Pharmacol 1992; 106:324-30.
139. Abman SH, Chatfield BA, Hall S, McMurtry IF. Role of EDRF during transition of pulmonary circulation at birth. Am J Physiol 1990; 259:H1921-7.
140. Hislop AA, Buttery LKD, Springall DR, Pollock J, Polak JM, Haworth SG. Postnatal changes in localisation of endothelial nitric oxide synthase in the porcine pulmonary vasculature (abstract). Am Rev Respir Dis 1993; 147:A224.
141. Li CG, Rand MJ. Evidence that part of the NANC relaxant response of guinea-pig trachea to electric field stimulation is mediated by nitric oxide. Br J Pharmacol 1991; 102:91-4.
142. G-nitro arginine inhibits non-adrenergic, non-cholinergic relaxations of guinea-pig isolated tracheal smooth muscle. BrJ Pharmacol 1990; 100:663-4.
143. Belvisi MG, Stretton CD, Yacoub M, Barnes PJ. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol 1992; 210:221-2.
144. Lilly CM, Stamler JS, Gaston BM, Loscalzo J, Drazen JM. NO-synthase modulates vasoactive intestinal peptide (VIP) pulmonary relaxation in superfused guinea pig lungs (abstract). Am Rev Respir Dis 1992; 145:A382.
145. Ollerenshaw S, Jarvis D, Woolcock A, Sullivan C, Scheibner T. Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Engl J Med 1989; 320:1244-8.
146. Dey RD, Dalal G, Pinkstaff CA, Mayer B, Kummer W, Said SI. Nitric oxide synthase and vasoactive intestinal peptide are colocalized in neurons of the ferret tracheal plexus (abstract). Am Rev Respir Dis 1993; 147:A288.
147. Diamond L, Lantta J, Thompson DC, Altiere RJ. Nitric oxide synthase inhibitors fail to affect cat airway nonadrenergic noncholinergic inhibitory (NANCI) responses (abstract). Am Rev Respir Dis 1992; 145:A382.
148. Ellis JL, Undem BJ. Inhibition by L-NG-nitro-L-arginine of nonadrenergicnoncholinergic-mediated relaxations of human isolated central and peripheral airway. Am Rev Respir Dis 1992; 147:1543-7.
149. Belvisi MG, Ward JK, Tadjkarimi S, Yacoub MH, Barnes PJ. Inhibitory NANC nerves in human airways: Differences in disease and after extrinsic denervation (abstract). Am Rev Respir Dis 1993; 147:A286.
150. Belvisi MG, Stretton D, Barnes PJ. Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea-pig airways. Eur J Pharmacol 1991; 198:219-21.
151. 1-receptor-mediated cyclic GMP production in guinea-pig lung tissue is an L-arginine-dependent process. Biochem Pharmacol 1991; 42: 271-7.
152. Sheng H, Ishii K, Murad F. Generation of an endothelium-derived relaxing factor-like substance in bovine tracheal smooth muscle. Am J Physiol 1991; 260:L489-93.
153. Kuo H-P, Liu S, Barnes PJ. The effect of endogenous nitric oxide on neurogenic plasma exudation in guinea-pig airways. Eur J Pharmacol 1992; 221:385-8.
154. Mulligan MS, Heves JM, Marietta MA, Ward PA. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA 1991; 88:6338.
155. Mulligan MS, Warren JS, Smith CW, Anderson DC, Yeh CG, Rudolph AR, Ward PA. Lung injury after deposition of IgA immune complexes: requirements for CD18 and L-arginine. J Immunol 1992; 148:3086-92.
156. Miwa M, Stuehr DJ, Marietta MA, Wishnok JS, Tannenbaum SR. Nitrosation of amines by stimulated macrophages. Carcinogenesis 1987; 8:955-8.
157. Mulligan MS, Moncada S, Ward PA. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br J Pharmacol 1992; 107:1159-62.
158. Jorens PG, Van Overeld FJ, Bult H, Vermeire PA, Herman AG. Serineprotease inhibitors modulate nitric oxide-synthase activity of alveolar macrophages. Agents Actions 1992; 36:243-7.
159. Di Rosa M, Radomski M, Carnuccio R, Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun 1990; 172:1246-52.
160. Burkart V, Imai Y, Kallmann B, Kolb H. Cyclosporin A protects pancreatic islet cells from nitric oxide-dependent macrophage cytotoxicity. FEBS Lett 1992; 313:56-8.
161. Oswald IP, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J Immunol 1992; 148:3578-82.
162. Holt PG, Oliver J, Bilyk N, McMenamin C, McMenamin PG, Krall G, Thepen T. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 1993; 177:397-407.
163. Jain B, Rubinstein I, Robbin RA, Leise KL, Sisson JH. Nitric oxide modulates ciliary activity in airway epithelium (abstract). Am Rev Respir Dis 1993; 147:A937.
164. Smith WDA. A history of nitrous oxide and oxygen anesthesia, part X: The early manufacture, storage and purity of nitrous oxide. Br J Anaesth 1967; 39:351-81.
165. Miller RD, ed. Anesthesia. 3rd ed. New York: Churchill Livingstone, 1990; 51-104.
166. 3H]Naloxone displacement: evidence for nitrous oxide as opioid receptor agonist. Eur J Pharmacol 1983; 89:177-8.
167. Ori C, Ford-Rice F, London ED. Effects of nitrous oxide and halothane on μ and κ opioid receptors in guinea-pig brain. Anesthesiology 1989; 70:541-4.
168. Marshall BE, Longnecker DE. General anesthetics. In: Gilman AG, Rall TW, Nies AS, Taylor P, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990; 285-310.
169. Rowland AS, Baird DD, Weinberg CR, Shore DL, Shy CM, Wilcox AJ. Reduced fertility among women employed as dental assistants exposed to high levels of nitrous oxide. N Engl J Med 1992; 327:993-7.
170. Baird PA. Occupational exposure to nitrous oxide: not a laughing matter. N Engl J Med 1992; 327:1026-7.
171. Makar AB, Tephly TR. Effect of nitrous oxide and methionine treatments on hepatic S-adenosylmethionine and methylation reactions in the rat. Mol Pharmacol 1983; 24:124-8.
172. Sowa S, Dong A, Roos EE, Caughey WS. The anesthetic nitrous oxide affects dioxygen utilization by bovine heart and bean seed mitochondrial particles. Biochem Biophys Res Commun 1987; 144:643-8.
173. Einarsdóttir Ó, Caughey WS. Interactions of the anesthetic nitrous oxide with bovine heart cytochrome c oxidase: effects on protein structure, oxidase activity, and other properties. J Biol Chem 1988; 263: 9199-9205.
174. Borland CDR, Higenbottam TW. A simultaneous single breath measurement of pulmonary diffusing capacity with nitric oxide and carbon monoxide. Eur Respir J 1989; 2:56-63.
175. Windholz M, ed. Merck Index: an encyclopedia of chemicals, drugs and biologicals. 10th ed. Rahway, NJ: Merck & Co., 1983; 6423.
176. Meyer M, Schuster K-D, Schultz H, Mohr M, Piiper J. Pulmonary diffusing capacities for nitric oxide and carbon monoxide determined by rebreathing in dogs. J Appl Physiol 1990; 68:2344-57.
177. Meyer M, Piiper J. Nitric oxide, a new test gas for study of alveolar-capillary diffusion. Eur Respir J 1989; 2:494-6.
178. Frostell C, Högman M, Hedenstrom H, Hedenstierna G. Is nitric oxide inhalation beneficial for the asthmatic patient? (abstract). Am Rev Respir Dis 1993; 147:A515.
179. Blomqvist H, Wickerts CJ, Andreen M, Ullberg U, Örtqvist Å, Frostell Enhanced pneumonia resolution by inhalation of nitric oxide? Acta Anaesthesiol Scand 1993; 37:110-4.
180. World Health Organization. Environmental Health Criteria 4: oxides of nitrogen. Geneva: World Health Organization, 1977.
181. x: an overview. J Toxicol Environ Health 1984; 13:205-27.
182. Lowry T. "Silo-filler's disease": a syndrome caused by nitrogen dioxide. JAMA 1956; 162:153.
183. Zwemer FL Jr, Pratt DS, May JJ. Silo filler's disease in New York state. Am Rev Respir Dis 1992; 146:650-3.
184. Grayson RR. Silage gas poisoning: nitrogen dioxide pneumonia, anew disease in agricultural workers. Ann Intern Med 1956; 45:393-408.
185. Norman V, Keith CH. Nitrogen oxides in tobacco smoke. Nature 1965; 205:915-6.
186. Austin AT. The chemistry of the higher oxides of nitrogen as related to the manufacture and administration of nitrous oxide. Br J Anaesth 1967; 39:345-50.
187. Neto LM, Nascimento OR, Tabak M, Caracelli I. The mechanism of reaction of nitrosyl with met- and oxymyoglobin: an ESR study. Biochim Biophys Acta 1988; 956:189-96.
188. Chiodi H, Mohler JG. Effects of exposure of blood hemoglobin to nitric oxide. Environ Res 1985; 37:355-63.
189. Shiel FO. Morbid anatomical changes in the lungs of dogs after inhalation of higher oxides of nitrogen during anesthesia. Br J Anaesth 1967; 39:413-24.
190. Mirvish SS, Wallcave L, Eagen M, Shubik P. Ascorbate-nitrite reaction: possible means of blocking the formation of carcinogenic N-nitroso compounds. Science 1972; 177:65-8.
191. Suzuki Y. Reduction of hexavalent chromium by ascorbic acid in rat lung lavage fluid. Arch Toxicol 1988; 62:116-22.
192. Groll-Knapp E, Haider M, Kienzl K, Handler A, Trimmel M. Changes in discrimination learning and brain activity (ERP's) due to combined exposure to NO and CO in rats. Toxicology 1988; 49:441-7.
193. Kandel ER, O'Dell TJ. Are adult learning mechanisms also used for development? Science 1992; 285:243-6.
194. Snyder SH. Nitric oxide: first in a new class of neurotransmitters? Science 1992; 257:494-6.
195. Schmidt HHHW, Warner TD, Ishii K, Sheng H, Murad F. Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science 1992; 255:721-3.
196. von Nieding G, Wagner HM, Krekeler H. Investigation of the acute effects of nitrogen monoxide on lung function in man. Proceedings, Third International Clean Air Congress. Dusseldorf: Verlag des Vereins Deutcher Ingenieure, 1973; A14-16.
197. Kagawa J. Respiratory effects of 2-hr exposure to 1.0 ppm nitric oxide in normal subjects. Environ Res 1982; 22:485-90.
198. Hugod C. Ultrastructural changes of the rabbit lung after 5 ppm nitric oxide exposure. Arch Environ Health 1979; 34:12-7.
199. Mercer RR, Costa DL, Crapo JD. Alveolar septal injury from low level exposures to nitric oxide (abstract). Am Rev Respir Dis 1993; 147:A385.
200. 2. Arch Environ Health 1972; 24:180-8.
201. Williams RA, Rhoades RA, Adams WS. The response of lung tissue and surfactant to nitrogen dioxide exposure. Arch Intern Med 1971; 128:101-8.
202. Maples KR, Sandstrom T, Su Y-F, Henderson RF. The nitric oxide/heme protein complex as a biologic marker of exposure to nitrogen dioxide in humans, rats and in vitro models. Am J Respir Cell Mol Biol 1991; 4:538-43.
203. Postlethwait EM, Langford SD, Bidani A. Reactive absorption of nitrogen dioxide by pulmonary epithelial lining fluid. J Appl Physiol 1990; 69:523-31.
204. Carson JL, Collier AM, Hu SS, Devlin RB. Effect of nitrogen dioxide on human nasal epithelium. Am J Respir Cell Mol Biol 1993; 9:264-70.
205. Devalia JL, Campbell AM, Sapsford RJ, Rusznak D, Quint P, Godard JB, Davies RJ. Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 1993; 9:271-8.